News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Clinical
Prostate cancer detection made easier—and safer
Let’s say you’re a person with a prostate, and you’ve just had that gland checked with a prostate-specific antigen (PSA) test. Results show an elevated PSA level, which may or may not mean you have cancer. What do you do next? If you are being cared for by a Washington University urologic surgeon at Barnes-Jewish […]
Clinical
A complete toolkit for brain-tumor treatment
Every week, the brain tumor and neuro-oncology program at the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine holds a tumor board meeting. Attending are specialists in the field of brain-tumor diagnosis and treatment: neurosurgeons, neuro-oncologists, neuro-radiation oncologists, endocrinologists and neuro-intensivists, as well as representatives from psychology, neurology, genetics, […]
Research
Immunotherapy for newly diagnosed endometrial cancer
For the first time ever, investigators are studying immunotherapy for patients with newly diagnosed endometrial cancer. The trial uses pembrolizumab, a programmed death receptor-1 (PD-1) inhibitor. The drug is currently approved by the Food and Drug Administration for treatment of advanced melanoma and metastatic non-small-cell lung cancer. “Pembrolizumab has been studied in patients with relapsed […]
In the Media
Siteman Investment Program awards $2.2 million in cancer research grants
Research on breast cancer and the effects of chemotherapy are among the seven projects that will benefit from $2.2 million in new grants announced by Siteman Cancer Center through its Siteman Investment Program. The goal of the grants is to support and accelerate the pace of innovation in cancer research. The money awarded comes from a variety of sources: […]
Research
Pathway linked to slower aging also fuels brain cancer
While a particular metabolic pathway shows potential to slow down the aging process, new research indicates a downside: That same pathway may drive brain cancer. The pathway, known as the nicotinamide adenine dinucleotide (NAD+) pathway, is overactive in a deadly form of brain cancer known as glioblastoma, according to a study by researchers at Washington […]
Research
In highly lethal type of leukemia, cancer gene predicts treatment response
Patients with the most lethal form of acute myeloid leukemia (AML) – based on genetic profiles of their cancers – typically survive for only four to six months after diagnosis, even with aggressive chemotherapy. But new research indicates that such patients, paradoxically, may live longer if they receive a milder chemotherapy drug. Treatment with the […]
Research
New topical immunotherapy effective against early skin cancer
A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from Washington University School of Medicine in St. Louis and Harvard Medical School, shows that the therapy activates the immune system’s T cells, which then attack […]
Research
Weight loss may help prevent multiple myeloma
New research shows that excess weight increases the risk that a benign blood disorder will progress into multiple myeloma, a cancer of the blood. The study, by a team at Washington University School of Medicine in St. Louis, is published Nov. 18 in the Journal of the National Cancer Institute. Being overweight or obese has […]
Staff/Faculty Update
Achilefu named to chemistry, optical societies
Samuel Achilefu, PhD, the Michel M. Ter-Pogossian Professor of Radiology at Washington University School of Medicine in St. Louis, has been elected as a fellow to the Royal Society of Chemistry and to The Optical Society. The Royal Society of Chemistry is a London-based professional association of chemical scientists with more than 50,000 members worldwide. […]
Research
Siteman fund grants $300,000 for unique approaches to fighting cancer
Two scientists at Washington University School of Medicine in St. Louis and Siteman Cancer Center will receive a combined $300,000 in funding over two years for their innovative approaches to fighting cancer. The awards, from the Alvin J. Siteman Cancer Research Fund, are meant to further promising early-stage science that because of its unconventional approach […]